TY  - ADVS
AU  - McDermott,David
TI  - Immune checkpoint blockade in renal cell carcinoma
T2  - Immunotherapy of cancer,
PY  - 2016///
CY  - London
PB  - Henry Stewart Talks
KW  - Antineoplastic agents
KW  - Cancer
KW  - Immunological aspects
KW  - Immunotherapy
KW  - Kidneys
KW  - Chemotherapy
KW  - Renal cell carcinoma
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - immunology
KW  - Cell Cycle Checkpoints
KW  - Clinical Trials as Topic
KW  - Combined Modality Therapy
KW  - CTLA-4 Antigen
KW  - methods
KW  - Kidney Neoplasms
KW  - Patient Selection
KW  - Programmed Cell Death 1 Receptor
KW  - antagonists & inhibitors
KW  - T-Lymphocytes
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Recent data that has led to the approval of PD-1 blockade in RCC -- Approaches to patient selection --   Novel combination therapies that are entering pivotal trials; Access restricted to subscribers
UR  - https://hstalks.com/bs/3242/
UR  - https://hstalks.com/bs/p/896/
UR  - https://hstalks.com/bs/p/980/
ER  -